학술논문

Immunogenicity and safety in healthy adults of full dose versus half doses of COVID-19 vaccine (ChAdOx1-S or BNT162b2) or full-dose CoronaVac administered as a booster dose after priming with CoronaVac: a randomised, observer-masked, controlled trial in Indonesia
Document Type
Article
Source
In: The Lancet Infectious Diseases. (The Lancet Infectious Diseases, May 2023, 23(5):545-555)
Subject
Language
English
ISSN
14744457
14733099